Literature DB >> 24052514

Polypill is not a 'vaccine-like' solution for primary cardiovascular disease prevention in all parts of the world.

Zeljko Reiner.   

Abstract

Entities:  

Keywords:  Ischaemic Heart Disease; Randomised Trials; Vaccination

Mesh：

Substances：

Year:  2013        PMID： 24052514     DOI： 10.1136/jech-2013-203220

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN： 0143-005X            Impact factor:   3.710


× No keyword cloud information.
  3 in total

Review 1.  Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.

Authors:  Ehete Bahiru; Angharad N de Cates; Matthew Rb Farr; Morag C Jarvis; Mohan Palla; Karen Rees; Shah Ebrahim; Mark D Huffman
Journal:  Cochrane Database Syst Rev       Date:  2017-03-06

2.  General practitioners' use of absolute risk versus individual risk factors in cardiovascular disease prevention: an experimental study.

Authors:  Jesse Jansen; Carissa Bonner; Shannon McKinn; Les Irwig; Paul Glasziou; Jenny Doust; Armando Teixeira-Pinto; Andrew Hayen; Robin Turner; Kirsten McCaffery
Journal:  BMJ Open       Date:  2014-05-15       Impact factor: 2.692

Review 3.  The use of expensive technologies instead of simple, sound and effective lifestyle interventions: a perpetual delusion.

Authors:  Silvia Carlos; Jokin de Irala; Matt Hanley; Miguel Ángel Martínez-González
Journal:  J Epidemiol Community Health       Date:  2014-06-24       Impact factor: 3.710
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.